Sort   by:  
 Page size 
UnknownNeurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study.
Not available
S-EPMC4303775 | biostudies-literature
UnknownGenetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy.
Not available
S-EPMC4140681 | biostudies-literature
UnknownAbsence of neurocognitive effect of hepatitis C infection in HIV-coinfected people.
Not available
S-EPMC4335996 | biostudies-literature
UnknownMitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.
Not available
S-EPMC4599391 | biostudies-literature
UnknownNormative data and validation of a regression based summary score for assessing meaningful neuropsychological change.
Not available
S-EPMC3151558 | biostudies-literature
UnknownPrevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.
Not available
S-EPMC5225254 | biostudies-literature
UnknownPost-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.
Not available
S-EPMC11381616 | biostudies-literature
Sort   by:  
 Page size